Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430423 · ClinicalTrials.gov registry record
The FLOW Registry.
A clinical trial, sponsored by University of Chicago.
- Not yet
- Registry status
- 3,000
- Enrollment target
NCT07430423: Clinical Trial study, sponsored by University of Chicago.
NCT07430423 is a clinical trial that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07430423 has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquablation of the prostate. All patients undergoing Aquablation of the prostate will be enrolled in the registry. Historical data from 1/1/2024- 11/30/2025 will be added through chart review. Current and future patient data will be collected through chart review during the subject's clinical care. Only data available in the electronic medical record will be collected and no additional data will be collected for research purposes. No biospecimens will be collected, and there are no physical risks from study participation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-08 |
| Est. Completion | 2036-12 |
What is known before NCT07430423 opens enrollment
NCT07430423 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07430423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07430423 about?
NCT07430423 is a clinical study titled "The FLOW Registry.". The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquablation of the prostate. All patients undergoing Aquablation of the prostate will be enrolled in the registry. Historical data from 1/1/2024- 11...
What is the current status of trial NCT07430423?
This trial is currently not yet recruiting. The enrollment target is 3,000 participants. The study started on 2026-08. Estimated completion is 2036-12.
Who is sponsoring clinical trial NCT07430423?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia